On ECHEMI
Home > Drugs > Central retinal vein occlusion
Central retinal vein occlusion
Central retinal vein occlusion is much more common than central retinal artery occlusion. Although visual impairment is not as dramatic as artery occlusion, it is also quite serious. In some cases, complete blindness may occur due to secondary neovascular glaucoma.
  • Site of disease:

    Eye
  • Infectious :

    Not contagious
  • Frequent population:

    Middle-aged and elderly people
  • Related symptoms:

    Visual impairment retinal hemorrhage and exudation retinal vein tortuosity and dilation vitreous blood stains retinal hemorrhage
  • Concurrent disease:

Related Drugs
Xuesetong Injection
Manufacturer:

Jiangsu Langou Pharmaceutical Co., Ltd.

Xuesetong Injection
Manufacturer:

Jiangsu Langou Pharmaceutical Co., Ltd.

Xuesetong Injection
Manufacturer:

Jiangsu Langou Pharmaceutical Co., Ltd.

Xuesetong Injection
Manufacturer:

HeiLongJiang ZBD Pharmaceutical Co., Ltd.

Xuesetong Injection
Manufacturer:

Hebei Changtian Pharmaceutical Co., Ltd.

Xuesetong Injection
Manufacturer:

Xi`an Han Feng Pharmaceutical Co., Ltd.

Xuesetong Injection
Manufacturer:

Yunnan Baiyao Group Co., Ltd.

Xuesetong Injection
Manufacturer:

KPC Pharmaceuticals, Inc.

Xuesetong Injection
Manufacturer:

Yunnan Baiyao Group Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.